PROTAC BRD9 Degrader-7, CAS [[3056013-04-5]]

Produktübersicht

• Artikelname: PROTAC BRD9 Degrader-7, CAS [[3056013-04-5]]
• Artikelnummer: MCE-HY-155361
• Hersteller Artikelnummer: HY-155361
• Alternativnummer: MCE-HY-155361-50MG,MCE-HY-155361-25MG,MCE-HY-155361-100MG,MCE-HY-155361-5MG,MCE-HY-155361-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

PROTAC BRD9 Degrader-7 is an orally active, selective BRD9 PROTAC degrader (DC50 = 1.02 nM). PROTAC BRD9 Degrader-7 mediates BRD9 degradation via the ubiquitin-proteasome system. PROTAC BRD9 Degrader-7 exhibits proliferation inhibitory activity in the MV4-11 cells. PROTAC BRD9 Degrader-7 can be used in the research of acute myeloid leukemia and other related malignancies. (Pink: BI 7271: HY-123616, Blue: 5-Aminothalidomide: HY-W023573, Blue + Black: Thalidomide-5-piperazine: HY-W834174, Black: N,N-Dimethylpiperazine: HY-W539783)[1].

Produkteigenschaften

• Molekulargewicht: 649.69
• Reinheit: 99.29
• CAS Nummer: [3056013-04-5]
• Formel: C36H35N5O7
• Target-Kategorie: Epigenetic Reader Domain,PROTACs

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound